Literature DB >> 24599924

Pancreatic cancer in the spotlight.

.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24599924     DOI： 10.1016/S1470-2045(14)70097-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  15 in total

1.  PNMA1 promotes cell growth in human pancreatic ductal adenocarcinoma.

Authors:  Shu-Heng Jiang; Ping He; Ming-Ze Ma; Yang Wang; Rong-Kun Li; Fang Fang; Ying Fu; Guang-Ang Tian; Wen-Xin Qin; Zhi-Gang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  CDK5/FBW7-dependent ubiquitination and degradation of EZH2 inhibits pancreatic cancer cell migration and invasion.

Authors:  Xin Jin; Chong Yang; Ping Fan; Jun Xiao; Wanli Zhang; Sudong Zhan; Tao Liu; Dejie Wang; Heshui Wu
Journal:  J Biol Chem       Date:  2017-02-27       Impact factor: 5.157

3.  3F-Box protein 32 degrades ataxia telangiectasia and Rad3-related and regulates DNA damage response induced by gemcitabine in pancreatic cancer.

Authors:  Chong Yang; Ping Fan; Shikai Zhu; Hongji Yang; Xin Jin; Heshui Wu
Journal:  Oncol Lett       Date:  2018-03-28       Impact factor: 2.967

4.  High Expression of Long Noncoding RNA HOTAIRM1 is Associated with the Proliferation and Migration in Pancreatic Ductal Adenocarcinoma.

Authors:  Yongyun Luo; Yaqin He; Xiaoping Ye; Jianjun Song; Qi Wang; Yukui Li; Xiaoliang Xie
Journal:  Pathol Oncol Res       Date:  2019-01-06       Impact factor: 3.201

5.  Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer.

Authors:  Haifeng Zong; Yang Zhang; Yong You; Tiantian Cai; Yehuang Wang
Journal:  Med Oncol       Date:  2015-02-21       Impact factor: 3.064

6.  SRPX2 promotes cell migration and invasion via FAK dependent pathway in pancreatic cancer.

Authors:  Zhenyuan Gao; Jingjing Zhang; Minghong Bi; Xiao Han; Zhengquan Han; Hongya Wang; Yimei Ou
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

7.  Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction.

Authors:  Xin Jin; Yunqian Pan; Liguo Wang; Tao Ma; Lizhi Zhang; Amy H Tang; Daniel D Billadeau; Heshui Wu; Haojie Huang
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

8.  Orthotopic inflammation-related pancreatic carcinogenesis in a wild-type mouse induced by combined application of caerulein and dimethylbenzanthracene.

Authors:  Chen Liang; Zhen Wang; Li Wu; Chen Wang; Bao-Hua Yu; Xiu-Zhong Yao; Xiao-Lin Wang; Ying-Yi Li
Journal:  Tumour Biol       Date:  2015-04-29

9.  Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer.

Authors:  Shenghua Tian; Pingping Li; Shi Sheng; Xin Jin
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

10.  Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.

Authors:  Shu-Heng Jiang; Yang Wang; Jian-Yu Yang; Jun Li; Ming-Xuan Feng; Ya-Hui Wang; Xiao-Mei Yang; Ping He; Guang-Ang Tian; Xiao-Xin Zhang; Qing Li; Xiao-Yan Cao; Yan-Miao Huo; Min-Wei Yang; Xue-Liang Fu; Jiao Li; De-Jun Liu; Miao Dai; Shan-Yun Wen; Jian-Ren Gu; Jie Hong; Rong Hua; Zhi-Gang Zhang; Yong-Wei Sun
Journal:  Oncotarget       Date:  2016-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.